Shaolong Li

发表

Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).

N. Lyu, Qifeng Chen, Jibin Li, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread.

Y. Kong, Peihong Wu, Li Xu, 2019, Journal of vascular and interventional radiology : JVIR.

Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study

J. Ni, Zhimei Huang, Tianqi Zhang, 2020, Abdominal Radiology.

CT-guided percutaneous radiofrequency ablation for lung neoplasms adjacent to the pericardium.

Lin Sun, Peihong Wu, N. Lyu, 2018, Lung cancer.

Tim-3 expression in glioma cells is associated with drug resistance

X. Xu, Ji Zhang, Shaolong Li, 2019, Journal of cancer research and therapeutics.

Integrating Postradiotherapy MRI‐Detected Lymph Node Necrosis and Pre‐ and Posttreatment Epstein–Barr Virus‐DNA for Risk Stratification in Nasopharyngeal Carcinoma

Lizhi Liu, Shaolong Li, Haojiang Li, 2022, Journal of magnetic resonance imaging : JMRI.

Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

Zhenfeng Zhang, Xiong-ying Jiang, N. Lyu, 2021, Journal for ImmunoTherapy of Cancer.

Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma

Minshan Chen, Yang-kui Gu, Jin-hua Huang, 2018, Journal of Cancer Research and Clinical Oncology.

Inflammatory cytokines and alpha-fetoprotein concentrations for predicting survival in patients with hepatocellular carcinoma

Yang-kui Gu, Jinhua Huang, Shaolong Li, 2019, Translational cancer research.

Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma

Zhenfeng Zhang, N. Lyu, Yanyu Zhang, 2020, Liver Cancer.

Programmed death ligand 1 as an indicator of pre-existing adaptive immune responses in human hepatocellular carcinoma

N. Lyu, Shaolong Li, Luwen Mu, 2016, Oncoimmunology.

Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma

Yuanyuan Shi, N. Lyu, Xin Huang, 2018, Cancer science.

Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers

Chaobin He, Jun Wang, Xin Huang, 2021, Journal of inflammation research.

Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study

Zaibo Jiang, A. Lin, N. Lyu, 2017, Journal of Cancer.

Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization as initial treatment for locally advanced hepatocellular carcinoma: a propensity score-matching analysis.

N. Lyu, M. Shi, Jibin Li, 2021, Journal of vascular and interventional radiology : JVIR.

Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma.

Y. Kong, Peihong Wu, Li Xu, 2018, Journal of hepatology.

Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results

Lin Sun, Peihong Wu, N. Lyu, 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma

Y. Kong, N. Lyu, Shaolong Li, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.